GALT logo

GALT

Galectin Therapeutics Inc.NASDAQHealthcare
$2.67-0.37%ClosedMarket Cap: $172.2M

As of 2026-04-06

Recent Analyst Ratings
DateFirmActionRatingPrevious
2025-12-17HC Wainwright & Co.Buy
2025-08-14HC Wainwright & Co.Buy
Forward Estimates
PeriodEPS Est.Revenue Est.# Analysts
Thu Dec 31$-0.41$179.7M1
Fri Dec 31$-0.45$385.2M1
Sun Dec 31$-1.06$572.2M1
Mon Dec 31$-0.91$23.1M1